P. Schöffski
Impact in
-
- Colorectal Cancer Treatments and Studies
-
- Testicular diseases and treatments
- Salivary Gland Tumors Diagnosis and Treatment
Papers in
- Oncology 8
- Cancer Treatment and Pharmacology 5
- Colorectal Cancer Treatments and Studies 4
- Lung Cancer Research Studies 1
-
- Lung Cancer Treatments and Mutations 4
- Sarcoma Diagnosis and Treatment 1
- Co-authors
- Hans‐Joachim Schmoll (3 shared papers)Carsten Bokemeyer (2 shared papers)J. Beyer (1 shared paper)A. Harstrick (1 shared paper)Lothar Kanz (1 shared paper)A. Gerl (1 shared paper)J. Casper (1 shared paper)N. Niederle (1 shared paper)
- Journals
- Journal of Clinical Oncology (6 papers)Annals of Oncology (4 papers)Clinical Oncology (1 paper)PubMed (3 papers)
- Partner nations
- GermanyBelgiumNetherlands
In The Last Decade
P. Schöffski
13 papers receiving 388 citations
Peers
Comparison fields: 5 of 51
- Oncology 138
- Surgery 125
- Cell Biology 44
- Biotechnology 23
- Pulmonary and Respiratory Medicine 75
Countries citing papers authored by P. Schöffski
This map shows the geographic impact of P. Schöffski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Schöffski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Schöffski more than expected).
Fields of papers citing papers by P. Schöffski
This network shows the impact of papers produced by P. Schöffski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Schöffski. The network helps show where P. Schöffski may publish in the future.
Co-authors
The 25 scholars most cited alongside P. Schöffski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 104 | |
| 2 | 2004 | 72 | |
| 3 | 2014 | 48 | |
| 4 | 2006 | 34 | |
| 5 | Cyclophosphamide, doxorubicin, and cisplatin in advanced salivary gland cancer. | 2011 | 29 |
| 6 | 2018 | 28 | |
| 7 | 2005 | 28 | |
| 8 | Interferon alpha-2b, 5-fluorouracil, and folinic acid combination therapy in advanced colorectal cancer: preliminary results of a phase I/II trial. | 1992 | 18 |
| 9 | 2008 | 16 | |
| 10 | 2014 | 9 | |
| 11 | 2010 | 6 | |
| 12 | 2012 | 4 | |
| 13 | The dead end of 5-fluorouracil double modulation and promise of continuous infusion schedules in the treatment of metastatic colorectal cancer. | 1996 | 1 |
| 14 | 2008 | 1 |
About P. Schöffski
P. Schöffski is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Cancer Research and Cell Biology, having authored 14 papers that have together received 398 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (5 papers), Lung Cancer Treatments and Mutations (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Cancer Genomics and Diagnostics (3 papers), Microtubule and mitosis dynamics (2 papers), Sarcoma Diagnosis and Treatment (1 paper), Lung Cancer Research Studies (1 paper) and Toxin Mechanisms and Immunotoxins (1 paper). The work is most often cited by research in Oncology (138 citations), Surgery (125 citations), Cell Biology (44 citations), Biotechnology (23 citations) and Pulmonary and Respiratory Medicine (75 citations). P. Schöffski has collaborated with scholars based in Germany, Belgium and Netherlands. Frequent co-authors include Hans‐Joachim Schmoll, Carsten Bokemeyer, J. Beyer, A. Harstrick, Lothar Kanz, A. Gerl, J. Casper, N. Niederle, Herlinde Dumez and Chris Twelves. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Oncology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.